Is Hikma Pharmaceuticals PLC stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hikma Pharmaceuticals PLC pays dividends. Last time was Monday 30th of September 2024 where the investors holding the stock on Monday 19th of August 2024 were paid $0.64 per share. Over the last 26 times between 2012 and 2024, Hikma Pharmaceuticals PLC has paid $10.43 with an average of $0.4 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hikma Pharmaceuticals PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $48.80, you would have made a profit of $2.30 per share or 4.71%
No, the average daily trading liquidity for Hikma Pharmaceuticals PLC is $170 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Hikma Pharmaceuticals PLC has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.44, the company's ability to pay off the debt is normal. Hikma Pharmaceuticals PLC has a good net profit margin of 6.62% and should have high tolerances against inflation.
We have calculated the inflation risk for Hikma Pharmaceuticals PLC to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.